Press Releases

January 08, 2018
Moderna Announces an Array of Clinical Advances and Outlines 2018 Priorities; 19 Development Candidates, including 10 Clinical Programs, Highlight Productivity of mRNA Platform
January 03, 2018
Dr. John Mendlein Joins Moderna as President, Corporate and Product Strategy
January 02, 2018
Moderna to Provide Corporate and Pipeline Updates and Outline Strategic Priorities at 2018 J.P. Morgan Healthcare Conference
December 19, 2017
Moderna Publishes Preclinical Data in Cell Reports on mRNA Therapeutic to Treat Rare Liver Disease Methylmalonic Acidemia (MMA), A Disorder of Organic Acid Metabolism
November 15, 2017
Moderna Announces First-in-Human Dosing for Phase 1 Study (KEYNOTE-603) of mRNA-4157, a Personalized Cancer Vaccine, for the Treatment of Solid Tumors
November 01, 2017
Moderna Announces New Collaboration with AstraZeneca to Co-Develop and Co-Commercialize Relaxin mRNA Therapeutic for Heart Failure
October 19, 2017
Moderna Named One of Global Biopharmaceutical Industry’s Top Employers in Science Magazine’s Annual Survey
October 10, 2017
Stephen Berenson Joins Moderna’s Board of Directors
September 26, 2017
Moderna Announces Publication in Molecular Therapy Characterizing Potent Immune Response Generated by Its mRNA Prophylactic Vaccines
September 14, 2017
Moderna Announces Pipeline and Corporate Update

Media Coverage

Science
December 19, 2017

Can a multibillion-dollar biotech prove its RNA drugs are safe for a rare disease?

Bloomberg
November 15, 2017

This $5 Billion Startup Made Its First Cancer Vaccine—For Just One Person

Endpoints News
September 14, 2017

AstraZeneca and Moderna take a big, early step forward in their quest to prove mRNA works in humans

FiercePharma
September 14, 2017

Moderna initiates Chikungunya vaccine human test, replaces backup Zika candidate

Reuters News
September 14, 2017

Moderna, AstraZeneca heart drug succeeds early-stage trial

Endpoints News
August 03, 2017

Top Novartis manufacturing exec jumps ship, takes charge of industrializing Moderna’s mRNA tech

FiercePharma
August 03, 2017

Moderna brings on former Novartis exec to oversee manufacturing of mRNA therapies

Boston Business Journal
August 03, 2017

Moderna taps Novartis exec to lead manufacturing blitz

BioPharma-Reporter.com
June 07, 2017

‘Don’t underestimate Merck’s vaccine business,’ says CEO

CNBC
May 16, 2017

Meet the 2017 CNBC Disruptor 50 Companies